Photocure Asa Stock Performance
| PHCUF Stock | USD 5.60 1.12 25.00% |
On a scale of 0 to 100, Photocure ASA holds a performance score of 8. The company holds a Beta of -0.81, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Photocure ASA are expected to decrease at a much lower rate. During the bear market, Photocure ASA is likely to outperform the market. Please check Photocure ASA's jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to make a quick decision on whether Photocure ASA's historical price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Photocure ASA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Photocure ASA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 334.9 M | |
| Total Cashflows From Investing Activities | -1.9 M |
Photocure |
Photocure ASA Relative Risk vs. Return Landscape
If you would invest 448.00 in Photocure ASA on September 29, 2024 and sell it today you would earn a total of 112.00 from holding Photocure ASA or generate 25.0% return on investment over 90 days. Photocure ASA is currently producing 0.424% returns and takes up 3.9668% volatility of returns over 90 trading days. Put another way, 35% of traded pink sheets are less volatile than Photocure, and 92% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Photocure ASA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Photocure ASA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Photocure ASA, and traders can use it to determine the average amount a Photocure ASA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1069
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PHCUF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.97 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Photocure ASA is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Photocure ASA by adding it to a well-diversified portfolio.
Photocure ASA Fundamentals Growth
Photocure Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Photocure ASA, and Photocure ASA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Photocure Pink Sheet performance.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 277.44 M | |||
| Shares Outstanding | 27.11 M | |||
| Price To Earning | 329.14 X | |||
| Price To Book | 5.72 X | |||
| Price To Sales | 0.77 X | |||
| Revenue | 360.54 M | |||
| EBITDA | 16.3 M | |||
| Cash And Equivalents | 283.87 M | |||
| Cash Per Share | 10.47 X | |||
| Total Debt | 12.5 M | |||
| Debt To Equity | 0.1 % | |||
| Book Value Per Share | 17.69 X | |||
| Cash Flow From Operations | 23.89 M | |||
| Earnings Per Share | (0.26) X | |||
| Total Asset | 789.65 M | |||
| Retained Earnings | 170 M | |||
| Current Asset | 175 M | |||
| Current Liabilities | 20 M | |||
About Photocure ASA Performance
By analyzing Photocure ASA's fundamental ratios, stakeholders can gain valuable insights into Photocure ASA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Photocure ASA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Photocure ASA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway. Photocure ASA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 97 people.Things to note about Photocure ASA performance evaluation
Checking the ongoing alerts about Photocure ASA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Photocure ASA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Photocure ASA had very high historical volatility over the last 90 days | |
| The company reported the revenue of 360.54 M. Net Loss for the year was (30.9 M) with profit before overhead, payroll, taxes, and interest of 336.49 M. |
- Analyzing Photocure ASA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Photocure ASA's stock is overvalued or undervalued compared to its peers.
- Examining Photocure ASA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Photocure ASA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Photocure ASA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Photocure ASA's pink sheet. These opinions can provide insight into Photocure ASA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Photocure Pink Sheet analysis
When running Photocure ASA's price analysis, check to measure Photocure ASA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Photocure ASA is operating at the current time. Most of Photocure ASA's value examination focuses on studying past and present price action to predict the probability of Photocure ASA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Photocure ASA's price. Additionally, you may evaluate how the addition of Photocure ASA to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |